Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Establishing a Diabetes Registry Using the JADE-DIAMOND Electronic Portal (CN001) [NA]
This trial update notes the completion of a diabetes registry project using the JADE-DIAMOND electronic portal, sponsored by the Asia Diabet…
-
FDA approval · 2015-03-03FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2015-02-25FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly, updating approval details for this product.
-
FDA approval · 2015-02-25FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
The FDA approved a supplemental application for Novo Nordisk's insulin aspart protamine and insulin aspart mix 70/30.
-
FDA approval · 2015-02-25FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN 70/30 (insulin human) from Eli Lilly and Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-02-25FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin N (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2015-02-25FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA has approved a supplemental application for NOVOLOG (insulin aspart) from Novo Nordisk. The approval relates to changes to the produ…
-
FDA approval · 2015-02-25FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects [Phase 1]
Phase 1 pharmacoscintigraphic study of NN9924 in healthy male volunteers, sponsored by Novo Nordisk A/S, has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-19Clinical Trial Update: A Trial Investigating the Absolute Bioavailability of Insulin Degludec in Healthy Subjects [Phase 1]
A Phase 1 study investigated the absolute bioavailability of insulin degludec in healthy subjects to characterize pharmacokinetic properties…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Safety and Efficacy of YH14617 in Diabetes Mellitus [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of YH14617 in diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Activating Brown Adipose Tissue Through Exercise [NA]
Clinical trial update from Universidad de Granada about activating brown adipose tissue through exercise in obesity and diabetes/metabolic s…
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: Evaluation of an Karajishi TS Investigational Blood Glucose Monitoring System [NA]
This clinical trial update reports the completion of a study evaluating the Karajishi TS investigational blood glucose monitoring system, wi…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus
A completed trial assessing long-term use of a continuous glucose monitoring (CGM) system in adult athletes with diabetes mellitus, sponsore…
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: Development of A Novel Anti-Hyperglycemic Agent [Phase 2]
A Phase 2 trial of a novel anti-hyperglycemic agent for diabetes was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-02-05Clinical Trial Update: OPTIFIT-Optimal Fiber Trial for Diabetes Prevention [NA]
Clinical trial update indicating the OPTIFIT trial evaluating optimal fiber for diabetes prevention has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: An Intervention for Elderly in Emergency Services [NA]
A completed clinical trial evaluating an intervention for elderly patients in emergency services, focusing on stroke, transient ischemic att…
-
CLINICAL_TRIALS trial_result · 2015-02-02Clinical Trial Update: Financial Incentives for Medication Adherence [NA]
A completed clinical trial from Boston Medical Center evaluated whether financial incentives improve adherence to medications in patients wi…
-
CLINICAL_TRIALS research · 2015-02-02Clinical Trial Update: Study of an Intervention to Improve Problem List Accuracy and Use [NA]
Clinical trial update from Brigham and Women's Hospital about a study to improve the accuracy and use of patients' problem lists across mult…
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: Metformin and Transient Hyperglycemia [NA]
Clinical trial update on metformin for transient hyperglycemia in children with acute lymphoblastic leukemia; the study was terminated and r…
-
CLINICAL_TRIALS trial_result · 2015-01-29Clinical Trial Update: Evaluation of Optimal Dosing Conditions for GLP-1 Analogue NNC0113-0987 When Administered Orally in Healthy Male Subjects [Phase 1]
This Phase 1 trial evaluates optimal oral dosing conditions for the GLP-1 analogue NNC0113-0987 in healthy male volunteers. The study status…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of Semaglutide [Phase 1]
Phase 1 pharmacokinetic study evaluating subcutaneous semaglutide at 1, 3, and 10 mg/mL and its absolute bioavailability; the trial has comp…
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying [Phase 2]
Phase 2 trial assessing the combined use of Lantus (insulin glargine) and Lyxumia (lixisenatide) to evaluate effects on insulin secretion an…
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Efficacy Study of Nicorandil on Neointima [Phase 4]
Phase 4 clinical trial update on nicorandil for neointima in patients with unstable angina and diabetes mellitus; no results or current stat…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Insulin Secretion in Diabetes Before and After Glycemic Control [NA]
A completed clinical trial from the US Department of Veterans Affairs examined insulin secretion in individuals with diabetes before and aft…